select trial semaglutide nejm A newly approved 7.2-mg dose of injectable lowered weight by 3 percentage points more than the standard 2.4-mg dose in clinical trials. "No formal medical criteria have been established for escalating Phase 3 Trial of Semaglutide

Combining GLP-1 medications with resistance training at least twice weekly, adequate protein intake (1.2-1.6 g/kg body weight daily), 150-300 minutes of moderate-intensity aerobic activity weekly, and prioritizing 7-9 hours of quality sleep significantly enhances abdominal fat reduction and preserves lean muscle mass

GIP receptor activation improves insulin sensitivity and may enhance fat oxidation and energy expenditure

The highest recommended Mounjaros weekly dose stands at 15 mg

Am Fam Physician 2010;81(4):4658.PubMed [21] Lam W, Bussom S, Guan F, Jiang Z, Zhang W, Gullen EA, et al

Cover Image Credit: Melnyk58 / 123RF.com (Licensed)